Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 5, 1999

View Archived Issues

NHLBI awards SBIR grant to Pentose for viral inactivation technology

Enzyme implicated in Alzheimer's disease discovered at SmithKline Beecham

Abgenix and Pfizer add third antigen target to collaboration agreement

Searle acquires two cardiovascular drugs from AstraZeneca in Europe and Scandinavia

Magainin to begin additional clinical trials of squalamine

Lorus Therapeutics completes acquisition of GeneSense

Glaxo Wellcome to market Crystacide in Latin America, Caribbean

Creative BioMolecules reports new data on OP-1 as a treatment for stroke

Promising drug targets in HCV identified by Schering-Plough

Scios licenses FGF rights to Chiron

Icos updates clinical trial program

Remune increases lymphocyte proliferation in HIV infection

FDA advisory panel recommends approval of PMDD treatment

Cantab and Glaxo Wellcome initiate phase II trials for DISC HSV vaccine

Amgen discusses top four late-stage products in pipeline

Synthetic cannabinoids with multiple pharmacological actions

Merck dedicates significant resources to development of nonpeptide GnRH antagonists

Malononitrilamide compound prolongs islet xenograft survival in combination with ciclosporin

Biogen halts all Antova studies following analysis of adverse events

The plot thickens: Pfizer makes surprise counteroffer for Warner-Lambert, files lawsuit

Interaction between FK-506 and prednisolone in islet xenotransplantion model

Breakthrough flu treatment approved by Health Canada

First approval granted for Melacine melanoma therapeutic vaccine

Health Canada approves Vioxx for once-daily treatment of osteoarthritis

U.S. is country of first launch for Raplon

Novel inhibitors of multidrug transporter mediating fluoroquinolone efflux

Manipulation of the cytokine pathway: an effective strategy for preventing pancreatitis?

Diacol is as effective as standard purgative therapy, with better patient preference, compliance

Large clinical trial to evaluate AG-7088 nasal spray as a common cold remedy commences

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...